WELL Health Expands Cardiac Monitoring with AliveCor Partnership
Event summary
- WELL Health partners with AliveCor to offer AI-powered cardiac monitoring with cardiologist oversight in Canada.
- Canadian-registered cardiologists from WELL’s network will review ECGs recorded via AliveCor’s Kardia app.
- Service aims to reduce cardiology wait times, which have increased by 53% over the last year in Canada.
- WELL Health will be compensated for each cardiologist review performed, generating clinical services revenue.
The big picture
This partnership aligns with the growing trend of AI-driven remote monitoring in healthcare, addressing critical gaps in cardiology services. With elective cardiology wait times averaging 15.3 weeks in Canada, the collaboration aims to provide faster, more accessible specialist care. WELL Health’s move into remote cardiac monitoring positions it to capitalize on the increasing demand for digital health solutions.
What we're watching
- Revenue Diversification
- How WELL Health’s compensation model for cardiologist reviews will impact its clinical services revenue.
- Market Expansion
- The pace at which WELL Health and AliveCor will expand the partnership beyond Canada.
- Integration Challenges
- Whether WELL Health can seamlessly integrate AliveCor’s Kardia 12L into its clinic network.
Related topics